Eligible Women Are 11 Percentage Points Less Likely to Get a Statin

TODAY'S TOPIC

Statins and Women

You have probably heard that statins cause muscle pain. Maybe you stopped taking yours because of it. Maybe someone you know did.

CLAIM 01

Most of the muscle pain people blame on statins is not actually caused by the statin.

VERDICT: TRUTH

Muscle aches are listed on every statin package insert, and up to 30% of real-world users report them. Many women quit the drug because of these symptoms, so the connection feels ironclad.

A 2022 Lancet meta-analysis of individual data from 19 double-blind trials, nearly 124,000 patients, found that only about 1 in 15 muscle pain reports during the first year were actually caused by the statin. Oxford researchers noted that 27.1% of the statin group reported muscle symptoms compared to 26.6% on placebo. The SAMSON trial, published in the New England Journal of Medicine in 2020, confirmed the pattern with well-established rigor: 90% of side effects patients attributed to statins also appeared when they took a placebo pill.

Many women who quit a statin over muscle pain were likely experiencing the nocebo effect, which is the flip side of placebo: expecting a side effect can produce real physical symptoms. In the SAMSON trial, half the participants who saw their own blinded results were able to restart the drug successfully.

The pill can be the trigger even when the molecule is not.

THE RESEARCH

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

New study shows muscle pain is not due to statins in over 90% of those taking the treatment

Statin side effects: Weigh the benefits and risks - Mayo Clinic

CLAIM 02

Taking a statin raises your risk of developing type 2 diabetes.

VERDICT: TRUTH

The FDA added a diabetes warning to statin labels in 2012, and the Women's Health Initiative reported a 48% increased diabetes risk among postmenopausal women taking statins. Numbers like that sound alarming enough to make anyone reconsider filling a prescription.

A 2010 Lancet meta-analysis of 13 trials with 91,140 participants found a 9% relative increase in diabetes risk, and a later analysis showed the increase is dose-dependent, larger with high-intensity statins and smaller with moderate doses. In absolute terms, treating 255 people with a statin for 4 years produced one extra diabetes case. The American Heart Association, drawing on well-established evidence from multiple large meta-analyses, estimates that for every extra diabetes case over that period, roughly 5 major coronary events were prevented.

The risk is real, dose-dependent, and highest in people already on the edge of a diabetes diagnosis. No major medical organization recommends stopping a statin over it. Staying aware of blood sugar while maintaining habits that lower diabetes risk is the recommended path.

The math still favors the statin.

THE RESEARCH

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

Statins may increase diabetes, but benefit still outweighs risk

CLAIM 03

Women who qualify for a statin are just as likely as men to be prescribed one.

VERDICT: MYTH

A 2015 meta-analysis of 174,000 participants confirmed that statins reduce cardiovascular risk comparably in women and men, and clinical guidelines draw no distinction by sex. You would expect the prescriptions to follow the evidence evenly. They do not.

A study published by the American Heart Association found that among eligible patients, 67% of women were treated with statins compared to 78% of men, and 18.6% of eligible women reported never being offered one at all. After a heart attack, an American College of Cardiology study found high-intensity statins were prescribed to 47% of women versus 56% of men. This prescribing gap is well-established across multiple large registry studies.

Women are less likely to be offered a statin, less likely to get the higher dose when they need it, and more likely to stop taking it. Knowing this gap exists is the first step toward a different conversation at a checkup.

The drug works the same; the offer does not.

Official guide

Why Do Women Get Cholesterol-Lowering Statins Less Frequently Than Men?

American Heart Association

THE RESEARCH

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials

Why do women get cholesterol-lowering statins less frequently than men?

Women Remain Less Likely to Receive High-Intensity Statins Following Heart Attack

THE BOTTOM LINE

The muscle pain is usually not from the drug. The diabetes risk is real but small next to the cardiac benefit. And the bigger problem may be that eligible women are not offered the prescription often enough.